Product Approval Information - Licensing Action
Proper name: Antihemophilic Factor (Recombinant)
Tradename: ReFacto
Manufacturer: Genetics Institute, Inc, Andover, MA, License #1163
Indication for Use: Control and prevention of hemorrhagic episodes and for short-term routine and surgical prophylaxis in patients with hemophilia A
Approval Date: 3/6/2000
Type of submission: Biologics license application
Approval Letter -
(PDF),
(Text)
Label -
(PDF)
SBA -
(PDF)
|